Cerebellum GP LLC boosted its stake in Amdocs Limited (NASDAQ:DOX) by 12.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,924 shares of the technology company’s stock after buying an additional 894 shares during the period. Amdocs accounts for approximately 0.3% of Cerebellum GP LLC’s investment portfolio, making the stock its 28th largest holding. Cerebellum GP LLC’s holdings in Amdocs were worth $572,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Accurate Investment Solutions Inc. bought a new position in shares of Amdocs in the fourth quarter worth $64,000. Tower Research Capital LLC TRC boosted its stake in Amdocs by 20.6% during the third quarter. Tower Research Capital LLC TRC now owns 1,000 shares of the technology company’s stock valued at $66,000 after buying an additional 171 shares in the last quarter. KCS Wealth Advisory bought a new position in Amdocs during the third quarter valued at about $99,000. Robecosam AG boosted its stake in Amdocs by 9.5% during the third quarter. Robecosam AG now owns 2,300 shares of the technology company’s stock valued at $151,000 after buying an additional 200 shares in the last quarter. Finally, Huntington National Bank boosted its stake in Amdocs by 7.6% during the third quarter. Huntington National Bank now owns 2,856 shares of the technology company’s stock valued at $189,000 after buying an additional 202 shares in the last quarter. 92.39% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts recently weighed in on DOX shares. Stifel Nicolaus raised their target price on Amdocs from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Citigroup raised their target price on Amdocs from $72.00 to $83.00 and gave the company a “buy” rating in a research note on Wednesday. JPMorgan Chase & Co. decreased their target price on Amdocs from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, November 13th. Finally, BidaskClub cut Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, January 11th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $74.25.
Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, November 12th. The technology company reported $1.08 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.08. Amdocs had a return on equity of 15.98% and a net margin of 11.73%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business posted $0.99 earnings per share. The company’s quarterly revenue was up 2.8% on a year-over-year basis. Sell-side analysts expect that Amdocs Limited will post 4.25 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 24th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.285 per share. This represents a $1.14 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend is Monday, December 30th. Amdocs’s dividend payout ratio is 28.01%.
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.
Featured Article: What is the Euro STOXX 50 Index?
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.